ConditionGestational Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Eligibility criteria
Qualifiers
Diagnosis of gestational diabetes during current pregnancy
age 18 or older
prescribed Dexcom G7
Disqualifiers
Pregestational diabetes
known skin adhesive allergy which inhibits ongoing use of CGM
chronic oral steroid use.
Trial design
Treatments tested in this trial
- continuous glucose monitor
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov